Genome-wide association studies (GWASs) are highly effective at identifying common risk variants for schizophrenia. Rare risk variants are also important ...
Feb 23, 2019 · Genome-wide association studies (GWAS) are highly effective at identifying common risk variants for schizophrenia. Rare risk variants are ...
Feb 23, 2019 · Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing ...
Feb 23, 2019 · Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing ...
Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. Denise Harold.
People also ask
What type of disease would be identified by exome sequencing?
Why might exome sequencing fail to identify a disease causing mutation in an affected person?
How is exome sequencing useful in identifying mutations?
What is the diagnostic rate of exome sequencing?
Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals ...
Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals ...
Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals ...
Jan 18, 2023 · Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing ...
Sep 2, 2024 · Here we re‐analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity‐by‐descent (IBD) mapping followed by exome sequencing ...